Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-228,593
Closed -$58.2M 3445
2025
Q2
$50M Buy
+228,593
New +$36.9M 0.22% 54
2025
Q1
Sell
-71,057
Closed -$11.6M 3153
2024
Q4
$11.8M Buy
71,057
+27,047
+61% +$4.8M 0.06% 197
2024
Q3
$7.5M Buy
+44,010
New +$6.37M 0.04% 304
2024
Q2
Sell
-32,309
Closed -$4.01M 2857
2024
Q1
$4.06M Buy
32,309
+7,127
+28% +$816K 0.02% 325
2023
Q4
$2.65M Buy
+25,182
New +$2.75M 0.02% 531
2023
Q3
Sell
-81,372
Closed -$9.42M 2907
2023
Q2
$9.69M Buy
+81,372
New +$8.41M 0.09% 150
2022
Q4
Sell
-202,055
Closed -$15.4M 2954
2022
Q3
$12.3M Buy
+202,055
New +$14.8M 0.13% 112
2022
Q2
Sell
-1,885,780
Closed -$156M 3508
2022
Q1
$156M Buy
1,885,780
+1,548,925
+460% +$125M 1.11% 7
2021
Q4
$29.4M Sell
336,855
-1,358,087
-80% -$128M 0.17% 59
2021
Q3
$148M Buy
1,694,942
+1,226,381
+262% +$108M 0.9% 7
2021
Q2
$36.5M Buy
468,561
+85,969
+22% +$6.73M 0.33% 42
2021
Q1
$26.8M Sell
382,592
-528,810
-58% -$34.2M 0.27% 42
2020
Q4
$59M Buy
911,402
+305,329
+50% +$18.2M 1.19% 13
2020
Q3
$36.2M Buy
606,073
+312,090
+106% +$17.7M 1.05% 13
2020
Q2
$16.2M Buy
293,983
+287,750
+4,617% +$15.2M 0.49% 36
2020
Q1
$301K Sell
6,233
-168,299
-96% -$8.69M 0.02% 494
2019
Q4
$9.25M Sell
174,532
-319,325
-65% -$17.6M 0.4% 36
2019
Q3
$27.2M Buy
493,857
+71,961
+17% +$3.98M 1.28% 11
2019
Q2
$24M Buy
+421,896
New +$22.8M 1.52% 11
2019
Q1
Sell
-33,674
Closed -$1.52M 711
2018
Q4
$1.52M Buy
33,674
+11,532
+52% +$553K 0.22% 75
2018
Q3
$1.14M Buy
+22,142
New +$1.08M 0.18% 91
2017
Q1
Sell
-17,093
Closed -$657K 151
2016
Q4
$657K Buy
17,093
+256
+2% +$10K 0.84% 18
2016
Q3
$661K Buy
+16,837
New +$686K 0.58% 18

Other funds holding ORCL

HRT Financial's ORCL Position: Q3 2025 in Review

HRT Financial sold out of Oracle (ORCL) in Q3 2025, closing a stake of 228,593 shares — an estimated $58.2M sold.

HRT Financial first reported a position in ORCL in Q3 2016 and held it in 23 quarters. The position peaked at $156M in Q1 2022. 3,820 funds tracked by Wall St. Rank hold ORCL as of Q3 2025.

  • HRT Financial reported no remaining Oracle position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 228,593 Oracle shares in Q3 2025, an estimated $58.2M.
  • HRT Financial first reported a position in Oracle in Q3 2016 and held it in 23 quarters.
  • HRT Financial's Oracle position peaked at $156M in Q1 2022.
  • 3,820 funds tracked by Wall St. Rank held Oracle as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.